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SUMMARY.-IgM was detected in the urines of 4 out of 17 patients with
Burkitt's lymphoma. This IgM emerged from Sephadex G 200 column in two
different peaks strongly suggesting sub-units of the intact molecule. IgM
was not detected in any of the control urines. The total protein excreted in the
urine of Burkitt's lymphoma patients is higher than in controls and may be
due to renal involvement. Intact IgA and IgG as well as fragments of IgG
were present in the urines of all Burkitt patients as well as in controls. Six
of 16 Burkitt's lymphoma patients had reduced serum levels of IgG. Four of
these also had reduced serum IgM. The low mean concentration of serum
IgM confirms our previous studies.
In 1966, Ngu et al. reported that in patients with Burkitt's lymphoma, the
serum IgM was significantly reduced whereas the serum IgG and IgA appeared
to be normal. It was thought that the presence of IgM in C.S.F. may in part
account for the reduced serum IgM in Burkitt's patients (Udeozo et al., 1968).
Transfer of tumour cells to the C.S.F. may also facilitate the passage of IgM into
the C.S.F. from the serum, or it may be that the C.S.F. tumour cells produce the
IgM in situ. Osunkoya et al. (1968) have shown that Burkitt's lymphoma cells
can synthesize immunoglobulins. On the other hand if sub-units of intact IgM
exist in the serum ofthese patients, such sub-units could be easily transferred into
the C.S.F. as well as filtered through the kidneys and this may account for the
reduced serum levels ofIgM in Burkitt's lymphoma patients. The present report
is concerned with the identification of the immunoglobulins in urines and sera of
Burkitt's lymphoma patients.
MATERIALS AND METHODS
Specimens.-24-hour urine samples and blood were collected from 17 untreated
patients with Burkitt's lymphoma, and 11 age-matched controls. There were
6 females in the Burkitt group and 2 in the control group. Both urines and sera
were preserved with 0.1% sodium azide solution. Samples of urines were kept
at 40 C. overnight and then filtered through a double layer of Whatman No. 1
paper to remove insoluble material. The separated sera were stored at -20° C.
Antisera.-Specific antisera to the various human immunoglobulins were
prepared locally in rabbits as well as obtained from Central Laboratory and Blood
Transfusion, Netherlands, and from Hyland Laboratories.
Concentration of urine samples.-After experimenting with several different
methods of concentrating the urinary proteins, best results were finally obtainedIMMUNOGLOBULINS IN BURKITT'S LYMPHOMA
with the negative low pressure ultrafiltration methods described by Everall and
Wright (1958). Samples were concentrated at 4° C. to about 100 to 500-fold.
The concentrates were centrifuged in the cold at 2000 r.p.m. before storing at
-20° C. until used.
Estimation of total proteins in urine.-The total proteins of the unconcentrated
urine samples were determined by the method of Lowry et al. (1951). After gel
filtration the protein content of the eluates were determined by measuring the
absorbance at 280 m,u.
Measurement of serum immunoglobulin concentrations
Immunoglobulin concentrations were determined by the radial diffusion
technique of Mancini et al. (1963) using Hyland Immunoplates.
Double diffusion in agar gel. Double diffusion in agar gel was by the technique
ofOuchterlony (1958).
Immunoelectrophoresis.-The method of Scheidegger (1955) was used.
Sephadex gel filtration. The urine concentrates were fractionated in the cold
by gel filtration on Sephadex G 200 (S.G. 200) (Pharmacia, Uppsala, Sweden)
after the method of Flodin and Killander (1962). Elution was with 0 9% saline.
Two ml. fractions constituting the various peaks were pooled and concentrated
by lyophilization. The lyophilized fractions were reconstituted in the minimum
volume ofion-free water and tested for the presence of specific proteins by double
diffusion in agargel.
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FiG. 1. Calibration chart of S.G. 200 column using different molecular weight markers.
I I I I I I I I
259260 H. MCFARLANE, R. 0. BARROW, V. A. NGU AND B. 0. OSUNKOYA
Molecular weight determination.-The void volume (Vo) ofthe Sephadex column
was determined before each runusing Blue Dextran 2000 (LctNo. 9097,Pharmacia,
Uppsala, Sweden). 0 5 ml. of0.5% Blue Dextran was pipetted on to the Sephadex
bed and the eluate volume was timed immediately after the last trace of the
coloured Blue Dextran had disappeared into the column bed. Two ml. aliquots
were collected and the extinction of the fractions was determined at 650 mjt.
The elution volume (Ve) of each fraction was taken as the volume of the
eluting buffer required to elute a particular protein peak. Whitaker (1963) has
shown that there is an excellent linear relationship between Ve/Vo and the log
molecular weight of the protein. Furthermore, the molecular weight of the
unknown protein can be calculated if Ve/Vo is determined for 5 to 8 different
proteins whose molecular weights (M.W.) are already known. As shown in Fig. 1,
we determined Ve/Vo on the same S.G. 200 column for horse heart cytochrome
C, M.W. 12,400; spermwhale myoglobin, M.W. 17,000; twice crystallized oval-
bumin M.W. 45,000; bovine serum albumin M.W. 67,000, and horse apoferritin
M.W. 480,000. These molecular weight markers were obtained from Mann
Research Laboratories, New York. The resulting calibration chart (Fig. 1)
was used for calculating the molecular weights of the various urinary protein
peaks obtained after gel filtration.
Whitaker (1963) using S.G. 100, also showed that the equation of the lines
obtained by plotting Ve/Vo against log M.W. is given by the " least squares"
equation.
Log M.W. = 0-973 ± 0*012 (V-1) + 5.190 ± 0-010 (Equation 1)
Leach and O'Shea (1965) using S.G. 200 have also shown that the molecular weight
of a protein can be calculated from Whitaker's equation:
Log M.W. = -0-981 (V
e ) I+ 5 845 (Equation 2)
RESULTS
The results obtained for the total protein concentration for urines and for the
serum immunoglobulins are shown in Table I. The statistical analysis of these
results is presented in Table II where it can be seen that the mean concentration
of total protein excreted in the urine of Burkitt patients was just significantly
(P < 0.05) higher than the controls. The mean urinary total protein concentra-
tion of 85-80 ± 13-60 mg./100 ml. in Nigerians, aged 7-17 years, gives a good
indication of the normal value of protein excreted. The decreased serum IgM
concentration shown in Tables I and II supports our previous finding that IgM
is significantly reduced in Burkitt's lymphoma. As shown in Table I, the serum
IgG concentration was decreased in 6 out of 16 Burkitt's patients. The IgA
values were similar in both patients and controls.
Sephadex gel filtration of urines
Peak 1.-Table III shows that on gel filtration of normal urine through Seph-
adex G 200 only IgA immunoglobulin was detected in peak 1. On the other
hand, with the urines from Burkitt's lymphoma patients, IgM when present, asIMMUNOGLOBULINS IN BURKITT S LYMPHOMA
TABLE I.-Urine and Serum Proteins in Burkitt's Lymphoma
Serum
Subjects
Burkitt's
O.M.
D.O.*
A.J.
B.S.
L.L.
S.A.
O.K.
A.0.
A.A.
O.J.
O.F.
G.S.
O.A.
O.T.*
A.G.
T.D.*
H.O.*
Normals
R.A.
T.U.
L.O.
R.O.
Y.O.
B.A.
A.M.
X.M.
B.O.
A.0.
O.S.
Age Urine protein IgM
(years) Sex (mg./100 ml.) (mg./ml)
15
7
5
13
7
11
7
12
8
10
9
7
8
7
7
8
9
15
14
13
8
10
7
7
61
7
8
13
F
M
M
F
M
M
M
F
M
M
F
M
M
M
M
F
F
F
F
M
M
M
M
M
M
M
M
M
110
108
105
115
160
158
120
140
160
105
125
105
55
115
113
263
190
98
84
90
88
95
60
90
90
88
95
115
0-47
0-80
0-28
0-30
0-45
0-23
0-39
1-00
0-51
1-30
1-00
0-48
0-55
0.46
0 54
0-39
1-31
1-20
0-76
1-50
0-94
1-10
1-24
0-94
1-75
1-40
1-40
IgG IgA
(mg./mrl.) (mg./ml.)
23-40
22-00
10-00
10-00
18-30
10-00
10-50
10-00
39-00
13-50
22-00
35-00
22-00
17-50
22 - 20
25-00
26-50
25-40
35-20
30-00
22-50
32-00
28-00
22-00
23-00
22-00
32-00
2-30
2-10
1-40
2-40
1-50
0-90
1-80
2-10
2-50
2-90
2-70
2-30
2-80
2-50
1 -90
2-10
2-25
2-40
2-50
2-80
1-28
1.90
1-90
2-30
1-50
2-70
3-10
* Patients withIgM in their urine.
Total prote
(mg./100 ml.)
IgM (mg./ml.)
TABLE II.-Statistical Analysis of the Results in Table I
Mean and
Subjects standard deviation Ranges Sigr
3in . Burkitt urine . 127-30±44-40 . 55-00-263 . < 0-C
Control urine .
Burkitt sera
- Control sera
IgG (mg./ml.) . Burkitt sera
Control sera
IgA (mg./ml.) . Burkitt sera
Control sera
90-27±12-97 .
0-57±0-30
60-115
0-23-1-30
(Ju
< O(C
(Vei
nificance
05
Lst significant)
001
)ry significant)
1-23±0-26 0-76-1-75 .
19-40±8-85 . 10-00-39-00 . < 0-025
(Significant)
27-15±4-65 . 22-00-35-20 .
2-37±0-54 . 0-90-2-90 . > 0-10
(Not significant)
2-24±0-64 1-90-3-10
well as IgA were detected in S.G. 200 peak 1. The elution volume of this peak
was near the void volume and in some cases the proteins in this peak emerged
with the void volume. It should be emphasized that S.G. 200 columns cannot be
used to determine molecular weight of proteins above 600,000 and therefore the
value which we obtained for the proteins in the first peak may be an index for the
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IgA only. It was for this reason that it appeared essential to include the results
obtained from both the calculations from Equation 2 and also from the calibration
chart in Fig. 1. The molecular weight ofthe proteins in this peak varied between
400,000 and 626,000 even for normal human serum which is known to contain
normal IgM of molecular weight of 900,000. The IgA in peak 1 may be a polymer
or aggregate ofIgA.
Peak 2.-As shown in Table III the proteins in this peak had M.W. between
140,000 and 230,000. The S.G. 200 peak 2 of normal as well as Burkitt urines
contain both IgA as well as IgG. In one Burkitt patient's urine IgM was also
detected in peak 2 and appeared to have a molecular weight in the range of 150,000
and 200,000. The precipitin lines of some Burkitt urine protein fractions formed
against anti Fab and anti Fc showed reactions of complete identity (Fig. 2)
suggesting that heavy polypeptide chain sub-units as well as intact IgG were
present in this peak.
1 2 3 Sample: 1 mlbconcentroted normal urine
Protein concentration-34mgIml.
Packing material: Sephadex G-200
(140x 400 u mesh)
Column dimension: 1 2 x 50 cm
Eluent: 0.9%/o Saline pH 7.4
Temperature: 23 °C
Flow rate: 10 ml./hr.
2- Fraction volume: 2 ml.
0.
10 20 30 40 50 60 70 80 90 100
< !c[IgG
U O xvIgA - - (ml) eluate
C.e Af IgM Negative
FIG. 3. S.G. 200 filtration pattern of a normal human urine. The distribution of the
immunoglobulins is indicated.
Peak 3.-The molecular weight of the proteins in this peak varied between
15,000 and 40,000. As shown in Table III the proteins present in the Burkitt
urines seems to have the smaller molecular weight. IgG and albumin were the
main proteins. In Fig. 2a and b the precipitin lines formed against anti Fab and
Fc showed a reaction of non-identity probably indicating that light polypeptide
chains as well as heavy polypeptide chains of IgG were present in this fraction.
Peak 4.-Although this peak did not appear to contain any protein, further
tests seem necessary to ascertain this. Fig. 3 shows a typical gel filtration pattern
ofa normal urine.
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Immunodiffusion
The immunodiffusion pattern ofone ofthe Burkitt urines which gave a positive
IgM precipitin line after gel filtration is shown in Fig. 2. Four patients with
Burkitt's lymphoma contained IgM in their urines. In the first patient IgM was
detected in both the concentrated whole urine as well as in the Sephadex G 200
peak 1. The urine ofthe second patient had IgM in peaks 1 and 2. In the third
patient, IgM was detected only in the concentrated whole urine. The fourth
urine was not fractionated but IgM was detected in the concentrated whole urine.
DISCUSSION
The significance of the IgM in the urines of 4 out of 17 Burkitt lymphoma
patients is not absolutely clear and needs further study. It is probable, however,
that the excretion of IgM into both the urine and C.S.F. may contribute to the
low levels of IgM which one so frequently encounters in the sera of Burkitt's
lymphoma patients. There is a strong indication that this urinary IgM represents
sub-units ofthe intact molecule. The degree ofproteinuria in Burkitt's lymphoma
patients is higher than in controls and may be the result of renal involvement.
The characteristics of the urinary IgG and IgA in Burkitt's lymphoma appear to
be similar to that found in the normal urine. Intact, as well as sub-units of IgG
were found in both. The control, as well as the Burkitt's lymphoma, urines had
some IgA molecules which appeared to be of larger molecular weight than the
normal serum IgA. It is probable that this IgA is of renal origin and may be
similar to exocrine IgA which also emerges from Sephadex peak in the void
volume and has a molecular weight of the same order as that described by Hong
et al. (1966) and Newcomb et al. (1968). On the other hand Portmans et al. (1967)
suggested that fragments of immunoglobulins may aggregate under conditions
employed in concentrating normal urine.
Six of 16 Burkitt's patients had markedly reduced serum IgG levels, and a
total of 12 patients had reduced serum lgM level. Four of the patients with low
IgG also had very low IgM. A recent article in Lancet (1969) stated that of
5 Burkitt lymphoma patients with reduced levels of serum IgG only one survived
while all 5 with normal IgG levels survived. It is clear that further work is
necessary to elucidate the dysgammaglobulinaemia that occurs in Burkitt's
lymphoma.
EXPLANATION OF PLATE
FIG. 2.-Photograph of a gel diffusion pattern (a), and its corresponding relevant line diagram
(b) of an immunodiffusion pattern of S.G. 200 gel filtration peaks 1, 2 and 3 of Burkitt's
urinary proteins.
Peak 1 shows precipitin lines against rabbit anti IgM and anti whole human sera.
Peak 2 shows lines against rabbit anti sera to Fab, Fc, whole human serum (wH) IgM,
and IgA. He is the control human serum.
Peak 3 shows precipitin lines against anti-Fab, Fc and anti whole human serum.
Abbreviations
M = Anti IgM
A = Anti IgA
wH = Anti whole human serum
Hs = Normal human serum
Fab = Anti papain fragment ofIgG with both heavy and light chains
Fc = Anti heavy chain fragment ofIgGBRITISH JOUTRNAL OF CANCER.
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